Siemens Healthineers opens its new Innovation Center in Erlangen
Siemens Healthineers has recently inaugurated its brand-new Innovation Center in Erlangen, Germany, located in the heart of the renowned Medical Valley, a regional hub for medical technology research. The center aims to foster open innovation by collaborating with external partners, start-ups, as well as academic and clinical institutions, with the ultimate goal of enhancing healthcare on a global scale. This new facility complements existing centers in Shanghai, China, and Bengaluru, India, forming a comprehensive network that promotes innovation, research, development, and customer-centric approaches.
Peter Schardt, the Chief Technology Officer (CTO) of Siemens Healthineers, emphasized the company’s dedication to the Erlangen and Forchheim regions, underlining their commitment to cultivating an open innovation culture. The primary objective is to collaboratively explore emerging technologies and value-added processes that can revolutionize the healthcare system for the benefit of patients worldwide. By encouraging open collaborations and joint projects, Siemens Healthineers aims to expand access to high-quality medical care, encompassing accurate diagnoses and appropriate therapies.
The new premises house various initiatives, including the ASOR community, which offers a co-working space to facilitate research and development in extended reality applications. This collaboration involves internal and external partners, aiming to make digital content more tangible and practical. The focus lies in testing, developing prototypes, and virtually simulating medical technology solutions and applications, particularly for training purposes.
Moreover, the Innovation Center serves as a hub for strategic partnerships, such as the digital health innovation platform d.hip. This platform brings together industry leaders, universities, medical institutions, and research organizations, with a shared objective of advancing the digitization of the healthcare system.
Siemens Healthineers has demonstrated its strong commitment to research and development, investing approximately €1.8 billion in fiscal year 2022. As a result of these efforts, the company holds an impressive portfolio of around 23,000 technical property rights, including approximately 15,000 granted patents.
© Siemens Healthineers
Post a comment